Delta Botanicals And Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -8.69%
- Profit Growth -14.69%
- Ebitda 1.37%
- Net Worth -132.75%
- Total Assets -41.22%
About Delta Botanicals And Research
Delta Botanicals And Research Private Limited (DBARPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 December 2018 (Six years and one month 25 days old ). Its registered office is in Bhubaneswar, Orissa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Susmita Mitra and Vikram Mitra serve as directors at the Company.
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100OR2018PTC030153
- Company No.
030153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Delta Botanicals And Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Mitra  | Managing Director | 31-Dec-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Susmita Mitra | Director | Current |
Financial Performance of Delta Botanicals And Research.
Delta Botanicals And Research Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.69% decrease. The company also saw a substantial fall in profitability, with a 14.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 132.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delta Botanicals And Research?
In 2023, Delta Botanicals And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ekloka Enterprises Private LimitedSusmita Mitra is a mutual person
- Mach Welfare Foundaton
Vikram Mitra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Delta Botanicals And Research?
Unlock and access historical data on people associated with Delta Botanicals And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delta Botanicals And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delta Botanicals And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
